Transforming Drug Discovery with Hybrid AI Innovation | By: Dr. Jo Varshney, CEO and Founder of VeriSIM Life

The integration of hybrid AI into the drug development process represents a transformative shift that will not only accelerate the discovery of new therapies but also enhance their precision and safety.